Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Communicating the Good, Bad & Ugly for CMOs and R&D Leaders in Biotech

  • Broadcast in Science
  • 0 comments
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:8822205
archived

This discussion provides helpful approaches for Chief Medical Officers (CMOs) and other R&D leadership in biotech on how to communicate effectively in times of good, bad or unexpected news. Also discussed in this program are factors to evaluate for the discontinuation of a program. Dr Mark Weinberg, Chief Medical Officer and Managing Director of Halloran Consulting Group will be joined by Dr Lee AllenCMO, Argos Therapeutics to discuss strategic communication strategies CMOs/R&D leadership can utilize to effectively deliver unexpected or difficult news.

 More specifically:

  • How do you communicate successfully?
  • How does a CMO manage an unexpected realization?
  • Tips on being an advocate and skeptic for your programs
  • Flexibility and decision making with data
  • Scenario planning
  • Tips on communicating to the public
  • Evaluating factors for discontinuing a program
  • Rationalizing your portfolio? Who decides?

Guests:

Lee Allen, MD, PhD, CMOArgos Therapeutics

Mark Weinberg, MD, MBA, CMO and Managing Director, Halloran Consulting Group

Producer:

Valerie Bowling,  Executive Director, PharmaTalk Radio & The Conference Forum

Recommended Conference: The CMO and R&D Biotech Leadership Summit, Nov 14-15 in San Francisco. For more info:

http://theconferenceforum.org/conferences/rdbiotechleadershipsummit/overview/

 

Comments

 comments